NRSN
Price
$1.14
Change
+$0.02 (+1.79%)
Updated
Aug 28 closing price
Capitalization
27.98M
89 days until earnings call
PBM
Price
$2.97
Change
-$0.14 (-4.50%)
Updated
Aug 28 closing price
Capitalization
695.81K
Interact to see
Advertisement

NRSN vs PBM

Header iconNRSN vs PBM Comparison
Open Charts NRSN vs PBMBanner chart's image
NeuroSense Therapeutics
Price$1.14
Change+$0.02 (+1.79%)
Volume$87K
Capitalization27.98M
Psyence Biomedical
Price$2.97
Change-$0.14 (-4.50%)
Volume$143.07K
Capitalization695.81K
NRSN vs PBM Comparison Chart in %
Loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRSN vs. PBM commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRSN is a Hold and PBM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (NRSN: $1.14 vs. PBM: $2.97)
Brand notoriety: NRSN and PBM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRSN: 27% vs. PBM: 7%
Market capitalization -- NRSN: $27.98M vs. PBM: $695.81K
NRSN [@Biotechnology] is valued at $27.98M. PBM’s [@Biotechnology] market capitalization is $695.81K. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRSN’s FA Score shows that 0 FA rating(s) are green whilePBM’s FA Score has 1 green FA rating(s).

  • NRSN’s FA Score: 0 green, 5 red.
  • PBM’s FA Score: 1 green, 4 red.
According to our system of comparison, PBM is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 5 TA indicator(s) are bullish while PBM’s TA Score has 2 bullish TA indicator(s).

  • NRSN’s TA Score: 5 bullish, 5 bearish.
  • PBM’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NRSN is a better buy in the short-term than PBM.

Price Growth

NRSN (@Biotechnology) experienced а 0.00% price change this week, while PBM (@Biotechnology) price change was -7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.15%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.12%.

Reported Earning Dates

NRSN is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (-1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($28M) has a higher market cap than PBM($696K). NRSN YTD gains are higher at: -5.000 vs. PBM (-82.339). NRSN has higher annual earnings (EBITDA): -8.55M vs. PBM (-46.56M). PBM has more cash in the bank: 1.93M vs. NRSN (666K). NRSN has less debt than PBM: NRSN (19K) vs PBM (2.5M). NRSN (0) and PBM (0) have equivalent revenues.
NRSNPBMNRSN / PBM
Capitalization28M696K4,023%
EBITDA-8.55M-46.56M18%
Gain YTD-5.000-82.3396%
P/E RatioN/A0.07-
Revenue00-
Total Cash666K1.93M34%
Total Debt19K2.5M1%
TECHNICAL ANALYSIS
Technical Analysis
NRSNPBM
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BILL49.207.57
+18.18%
BILL Holdings
PIII8.310.46
+5.92%
P3 Health Partners Inc
DAO8.930.22
+2.53%
Youdao
FI137.65-0.33
-0.24%
Fiserv
DOUG2.64-0.02
-0.75%
Douglas Elliman

NRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRSN has been loosely correlated with NEVPF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NRSN jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+1.79%
NEVPF - NRSN
49%
Loosely correlated
N/A
PBM - NRSN
35%
Loosely correlated
-4.50%
SLRX - NRSN
32%
Poorly correlated
-4.54%
CTMX - NRSN
31%
Poorly correlated
-0.97%
DNLI - NRSN
29%
Poorly correlated
+0.32%
More

PBM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBM has been loosely correlated with NEVPF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PBM jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-4.50%
NEVPF - PBM
54%
Loosely correlated
N/A
NRSN - PBM
36%
Loosely correlated
+1.79%
ATHA - PBM
28%
Poorly correlated
-1.13%
BCRX - PBM
27%
Poorly correlated
-0.59%
LQDA - PBM
25%
Poorly correlated
-1.93%
More